These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17674322)

  • 21. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.
    Dankmeyer JL; Fast RL; Cote CK; Worsham PL; Fritz D; Fisher D; Kern SJ; Merkel T; Kirschning CJ; Amemiya K
    J Immunol Res; 2014; 2014():341820. PubMed ID: 24995344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Adamovicz JJ; Amemiya K; Fast RL; Miller L; Opal SM; Palardy J; Parejo NA; Sörgel F; Kinzig-Schippers M; Drusano GL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3276-84. PubMed ID: 24687492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of Yersinia pestis pneumonia in aerosol-challenged BALB/c mice.
    Heine HS; Chuvala L; Riggins R; Hurteau G; Cirz R; Cass R; Louie A; Drusano GL
    Antimicrob Agents Chemother; 2013 May; 57(5):2010-5. PubMed ID: 23403418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis.
    Gelhaus HC; Anderson MS; Fisher DA; Flavin MT; Xu ZQ; Sanford DC
    Sci Rep; 2013; 3():1146. PubMed ID: 23359492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
    Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levofloxacin cures experimental pneumonic plague in African green monkeys.
    Layton RC; Mega W; McDonald JD; Brasel TL; Barr EB; Gigliotti AP; Koster F
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e959. PubMed ID: 21347450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of spore biology on the rate of kill and suppression of resistance in Bacillus anthracis.
    Drusano GL; Okusanya OO; Okusanya AO; van Scoy B; Brown DL; Fregeau C; Kulawy R; Kinzig M; Sörgel F; Heine HS; Louie A
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4718-25. PubMed ID: 19687233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.
    Arlen PA; Singleton M; Adamovicz JJ; Ding Y; Davoodi-Semiromi A; Daniell H
    Infect Immun; 2008 Aug; 76(8):3640-50. PubMed ID: 18505806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
    Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
    Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yersinia pestis: still a plague in the 21st century.
    Josko D
    Clin Lab Sci; 2004; 17(1):25-9. PubMed ID: 15011977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.
    Mwengee W; Butler T; Mgema S; Mhina G; Almasi Y; Bradley C; Formanik JB; Rochester CG
    Clin Infect Dis; 2006 Mar; 42(5):614-21. PubMed ID: 16447105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.